{
    "body": "What is the main mechanism by which human papillomavirus proteins E6 and E7 contribute to cell transformation?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10809724", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17768080", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9537653", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8207801", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21643539", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9223480", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20088881", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16249186", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8397367", 
        "http://www.ncbi.nlm.nih.gov/pubmed/1331501", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10698500", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17332339", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9817205", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21980285"
    ], 
    "ideal_answer": [
        "Although they may have other targets, human papillomavirus proteins E6 and E7 interact with and block the function of p53 and pRb, respectively, therefore deregulating cell cycle and leading to cellular transformation."
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D050725", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0019087"
    ], 
    "type": "summary", 
    "id": "5178444e8ed59a060a000037", 
    "snippets": [
        {
            "offsetInBeginSection": 816, 
            "offsetInEndSection": 1116, 
            "text": "The ability of high-risk HPV E6 and E7 protein to promote the degradation of p53 and pRb, respectively, has been suggested as a mechanism by which HPV oncogenes induce cellular transformation. E6 and E7 abrogate cell cycle checkpoints and induce genomic instability that leads to malignant conversion", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21643539", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 686, 
            "offsetInEndSection": 891, 
            "text": "The results showed that tumorigenicity and decreased serum requirement were associated with the ability of E6 to bind to p53, although the subsequent degradation of p53 was not required for these functions", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9537653", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 583, 
            "offsetInEndSection": 828, 
            "text": "The E7 mutants chosen had either an in-frame deletion in the conserved region 2 (CR2) domain, which is required for binding of the retinoblastoma tumor suppressor protein (pRb) and pRb-like proteins, or an in-frame deletion in the E7 CR1 domain.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9223480", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 416, 
            "text": "The recognition of a causal relationship between human papillomaviruses and cancer almost 30 years ago led to a rapid expansion of knowledge in the field, resulting in the description of the main mediators of HPV-induced carcinogenesis, the viral proteins E6 and E7. These oncoproteins show a remarkable pleiotropism in binding host-cell proteins, with the tumour suppressor genes p53 and pRb as their major targets.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17768080", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 567, 
            "offsetInEndSection": 793, 
            "text": "First, we found that human papillomavirus E6 and E7 oncogenes, which block the function of the p53 and Rb tumor suppressors, respectively, and SV40 small t antigen were required to allow mutant K-Ras(12D) growth transformation", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332339", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 427, 
            "offsetInEndSection": 618, 
            "text": "In recent years, it has become clear that in addition to E6-induced degradation of p53 tumor suppressor protein, other targets of E6 are required for mammary epithelial cells immortalization.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10809724", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 364, 
            "offsetInEndSection": 498, 
            "text": "a general requirement for oncoproteins such as human papillomavirus E6 and E7 has suggested that the p53 and Rb pathways are targeted.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9817205", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 142, 
            "text": "Transformation by the human papillomavirus (HPV) early gene products, E6 and E7, involves their interaction with cellular proteins p53 and Rb.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8207801", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1610, 
            "offsetInEndSection": 1939, 
            "text": "The results from this study support the theory that p53 protein binds HPV-16/18 E6 protein in the cell cytoplasm, thus preventing p53 from exerting its tumor-suppressor function in the nucleus. Hence, inactivation of wild-type p53 by p53-E6 complex formation in cervical cancer may be a critical step in malignant transformation.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8397367", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1191, 
            "offsetInEndSection": 1331, 
            "text": "the E7-RbAB interaction involves multiple motifs within the N-terminal domain of E7 and at least two conserved interaction surfaces in RbAB.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20088881", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 966, 
            "offsetInEndSection": 1053, 
            "text": "Based on these studies we present a mechanistic model for how E7 displaces E2F from pRb", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16249186", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 614, 
            "offsetInEndSection": 761, 
            "text": "The E7 protein of human papillomavirus type 16 contains an element that binds to pRB and appears to be functionally homologous to the E1A sequences", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/1331501", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 185, 
            "offsetInEndSection": 327, 
            "text": "Several of the biological activities of HPV16 E7 are mediated by inactivation of the members of the pocket protein family, pRb, p107 and p130.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10698500", 
            "endSection": "sections.0"
        }
    ]
}